Autopsy report · NCT04274114

Treatment of Adults With Generalized Anxiety Disorder Using Glutamine

“Inhability to recruit further participants due to SARS-CoV-2 pandemics.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 1 month after it had already started.
• Ran for about 1 year 4 months before it stopped.
• 38 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Hospital Universitario Dr. Jose E. Gonzalez

Sponsor type

University, hospital or other

Conditions

Generalized Anxiety Disorder

Interventions

L Glutamine; Placebos

Participants

38

Sites

1

Countries

Mexico

Trials that died the same way

• Respiratory Muscle Training in Stroke Swallowing Disorders
  “Because of the SARS-COV2 pandemic. Recruitment stopped at 48 patients” (79% match in meaning)
• Pre Bypass Ultrafiltration (PBUF) in Children Requiring Cardiopulmonary Bypass
  “Given SARS CoV2 pandemic, we had difficulty enrolling patients in the proposed time frame” (73% match in meaning)
• Digital Sedation: Virtual Reality Hypnosis During Colonoscopy
  “Recruitment too complicated during pandemics. Phase 2 of recruitment completed and enough data available.” (72% match in meaning)
• Clinical Study of PGT-A Versus PGT-A+ERA
  “Low recruitment speed, higher percentage drop-out and SARS-CoV-2 pandemic situation” (69% match in meaning)
• Intraocular Pressure and Optic Nerve Sheath Diameter Changes in Laparoscopic Cholecystectomies
  “As a result of COVID-19 pandemics” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.